BANKANSEBanka BioLoo LimitedMediumNeutral
Announced Tue, 26 May · 19:26 IST

Banka BioLoo Limited has informed the Exchange regarding Appointment of Ms Srilakshmi Manjula Chaitanya Chunduru as Company Secretary & Compliance Officer of the company w.e.f. May 26, 2026.

Management Changes View source PDF

BANKA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹85.31
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+4.0+6.1+8.2+8.4+8.4+6.3+7.6+5.5+11.7
Up moveDown movePending
AI summary

Banka BioLoo Limited reported a turnaround in profitability for FY2026 ending March 31, with standalone net profit of Rs. 38.21 lakhs compared to a loss of Rs. 929.64 lakhs in the previous year. Consolidated revenue grew to Rs. 5,709.24 lakhs with PAT of Rs. 39.31 lakhs versus a loss of Rs. 890.87 lakhs last year. The Board approved appointment of Ms. Srilakshmi Manjula Chaitanya Chunduru as Company Secretary and Compliance Officer effective May 26, 2026. The company also appointed M/s. SMAB & Associates as Internal Auditors for FY 2026-2027 and updated its Whistleblower policy. Key concerns include Rs. 687.44 lakhs in government receivables (Rs. 125.26 lakhs overdue over 2 years) and the ongoing CIRP proceedings of subsidiary Enzotech Solutions Pvt Ltd.

Likely market impact

The company returned to profitability after significant losses, though scale remains modest. The subsidiary's insolvency proceedings and high government receivables pose ongoing risks. Appointment of a new Company Secretary strengthens compliance governance.